Hapten-enhanced overall survival time in advanced hepatocellular carcinoma by ultro-minimum incision personalized intratumoral chemoimmunotherapy

Hapten-enhanced overall survival time in advanced hepatocellular carcinoma by ultro-minimum incision personalized intratumoral chemoimmunotherapy

Feng Gao,2 Peng Jing,2 Jian Liu,2 Yuanfei Lu,1 Peicheng Zhang,2 Wei Han,1 Guoliang Liu,1 Ning Ru,2 Guanghui Cui,2 Chenglin Sun,1 Yebing Che,1 Huaming Zhang,1 Qnglong Hu,3 Huan-you Wang,4 Yingli Wu,2 Changjiang Guan,2 Qiang Fu,1 Zhenlu Ma,2 Baofa Yu1–3 1Jinan Baofa Cancer Hospital, Jinan, P...

Full description

Bibliographic Details
Main Authors: Gao F, Jing P, Liu J, Lu YF, Zhang PC, Han W, Liu GL, Ru N, Cui GH, Sun CL, Che YB, Zhang HM, Hu QL, Wang HY, Wu YL, Guan CJ, Fu Q, Ma ZL, Yu BF
Format: Article
Language:English
Published: Dove Medical Press 2015-06-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
hapten
hepatocellular carcinoma
intratumoral chemoimmunotherapy
UMIPIC.
Online Access:https://www.dovepress.com/hapten-enhanced-overall-survival-time-in-advanced-hepatocellular-carci-peer-reviewed-article-JHC

Internet

https://www.dovepress.com/hapten-enhanced-overall-survival-time-in-advanced-hepatocellular-carci-peer-reviewed-article-JHC

Similar Items